Dr Susan Cleator, Consultant Clinical Oncologist
Dr Susan Cleator
Consultant Clinical Oncologist
Dr Susan Cleator BA BM Bch MRCP FRCR PhD
Consultant Clinical Oncologist
Dr Susan Cleator
Consultant Clinical Oncologist BA BM Bch MRCP FRCR PhD
Dr Cleator is a recommended Consultant Clinical Oncologist
Areas of expertise
- Breast cancer
- Radiotherapy
- Rectal cancer
- Chemotherapy
- Colorectal cancer
Recommendations for Dr Cleator
These recommendations are for information purposes only. Doctors providing recommendations do so in good faith and are not responsible for clinical outcomes.
Recommended by:
byA GP
❝Recommended oncologist❞
byA GP
❝Recommended oncologist❞
byDr James Mackay, Consultant Clinical Genetic Oncologist
❝Dr Susan Cleator is a specialist in breast cancer oncology.❞
byDr James Mackay, Consultant Clinical Genetic Oncologist
❝Dr Susan Cleator is a specialist in breast cancer oncology.❞
Make an appointment
Address
-
LOC at Chelsea
102 Sydney Street, Chelsea, London, SW3 6NJ
-
LOC - Leaders in Oncology Care
95-97 Harley Street, London, W1G 6AF
-
The Princess Grace Hospital
42-52 Nottingham Place, London, W1U 5NY
About Dr Susan Cleator
GMC number: 3680629
Year qualified: 1992
Place of primary qualification: Oxford University
Dr Cleator is an experienced breast and colorectal oncologist specializing in the delivery of chemotherapy, targeted treatments, and radiotherapy for both early and advanced disease. Her NHS base is at Imperial Healthcare Trust (Charing Cross), and she also consults privately at LOC, Harley Street. Additionally, she provides private treatment within the HCA and London Clinic facilities.
Dr Cleator received her initial medical training at Oxford University. She has a strong academic background, having completed a PhD at the Institute of Cancer Research and Royal Marsden Hospitals, where she studied gene profiling as a means of personalizing chemotherapy delivery. She remains actively involved in research and education.
Her particular interests include the treatment of breast cancer in young women and during pregnancy, neoadjuvant (pre-surgical) treatment, personalization of treatment using gene assays, and radiotherapy for early breast cancer. Dr Cleator is dedicated to advancing the field of oncology through her clinical practice and ongoing research.
Dr Cleator has been serving patients since her appointment and continues to contribute significantly to the medical community with her expertise and dedication.
Areas of expertise
- Breast chemotherapy
- Breast radiotherapy
- Colorectal cancer chemotherpy
- Colorectal radiotherapy
- Anal cancer
- Novel chemotherapy
- Biological agents
- General clinical oncology
Professional memberships
Articles by Dr Susan Cleator
Radical surgery versus organ preservation via short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (trec): a randomised, open-label feasibility study
Systemic inflammatory response syndrome in a patient diagnosed with high grade inflammatory triple negative breast cancer: a case report of a potentially rare paraneoplastic syndrome
The effect of the stromal component of breast tumours on prediction of clinical outcome using gene expression microarray analysis
Clinical translation of [18f]icmt-11 for measuring chemotherapy-induced caspase 3/7 activation in breast and lung cancer
Microarray-based comparative genomic hybridisation of breast cancer patients receiving neoadjuvant chemotherapy
Cleator s, ashworth amolecular profiling of breast cancer: clinical implications. br j cancer 90: 1120-1124
Ep-1199: cardiac dose delivered by left sided tumour bed electron boost; a potential source of toxicity
Common variation near cdkn1a, pold3 and shroom2 influences colorectal cancer risk
